Abstract
Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempting conception. Nevertheless, when conception occurs inadvertently during tamoxifen treatment, the effects on the fetus and on the course of pregnancy are still not completely known. Here, we report 3 cases of young women who accidentally became pregnant while taking tamoxifen and perform a systematic review of the literature to provide more elements for better and clear multidisciplinary counselling of women facing this challenging situation.
References
1.
Peccatori
FA
, Lambertini
M
, Scarfone
G
, Del Pup
L
, Codacci-Pisanelli
G
. Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences
. Cancer Biol Med
. 2018
Feb
;15
(1
):6
–13
.
[PubMed]
2095-39412.
Rosenberg
SM
, Newman
LA
, Partridge
AH
. Breast cancer in young women: rare disease or public health problem?
JAMA Oncol
. 2015
Oct
;1
(7
):877
–8
.
[PubMed]
2374-24373.
Fidler
MM
, Gupta
S
, Soerjomataram
I
, Ferlay
J
, Steliarova-Foucher
E
, Bray
F
. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study
. Lancet Oncol
. 2017
Dec
;18
(12
):1579
–89
.
[PubMed]
1470-20454.
Burstein
HJ
, Lacchetti
C
, Anderson
H
, Buchholz
TA
, Davidson
NE
, Gelmon
KA
, et al. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
. J Clin Oncol
. 2018
.
[PubMed]
0732-183X5.
Curigliano
G
, Burstein
HJ
, P Winer
E
, Gnant
M
, Dubsky
P
, Loibl
S
, et al.; St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017
. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
. Ann Oncol
. 2017
Aug
;28
(8
):1700
–12
.
[PubMed]
0923-75346.
Paluch-Shimon
S
, Pagani
O
, Partridge
AH
, Abulkhair
O
, Cardoso
MJ
, Dent
RA
, et al. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)
. Breast
. 2017
Oct
;35
:203
–17
.
[PubMed]
0960-97767.
Burstein
HJ
, Lacchetti
C
, Anderson
H
, Buchholz
TA
, Davidson
NE
, Gelmon
KE
, et al. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
. J Clin Oncol
. 2016
May
;34
(14
):1689
–701
.
[PubMed]
0732-183X8.
Braems
G
, Denys
H
, De Wever
O
, Cocquyt
V
, Van den Broecke
R
. Use of tamoxifen before and during pregnancy
. Oncologist
. 2011
;16
(11
):1547
–51
.
[PubMed]
1083-71599.
Sonmezer
M
, Oktay
K
. Fertility preservation in young women undergoing breast cancer therapy
. Oncologist
. 2006
May
;11
(5
):422
–34
.
[PubMed]
1083-715910.
Castro-Sanchez
A
, Martinez-Cannon
BA
, Platas
A
, Mohar
A
, Fonseca
A
, Vega
Y
, et al. Suboptimal Use of Effective Contraceptive Methods in Young Mexican Women With Breast Cancer
. J Glob Oncol
. 2018
Oct
;4
(4
):1
–7
.
[PubMed]
2378-950611.
Barthelmes
L
, Gateley
CA
. Tamoxifen and pregnancy
. Breast
. 2004
Dec
;13
(6
):446
–51
.
[PubMed]
0960-977612.
Physicians’ Desk Reference Health
; Nolvadex; 2003
.13.
Mehta
DK
, editor. Pregnancy. British National Formulary No. 45
. London
: British Medical Association and Royal Pharmaceutical Society
; 2004
. p. 726
. [Appendix 4
].14.
Briggs
GG
, Freeman
RK
, Yaffe
SJ
. Drugs in pregnancy and lactation
. 6th ed. Philadelphia
: Williams & Wilkins
; 2002
. pp. 1307
–13
.15.
Pagani
O
, Ruggeri
M
, Manunta
S
, Saunders
C
, Peccatori
F
, Cardoso
F
, et al. Pregnancy after breast cancer: are young patients willing to participate in clinical studies?
Breast
. 2015
Jun
;24
(3
):201
–7
.
[PubMed]
0960-977616.
Zubor
P
, Kubatka
P
, Kapustova
I
, Miloseva
L
, Dankova
Z
, Gondova
A
, Bielik
T
, Krivus
S
, Bujnak
J
, Laucekova
Z
, Kehrer
C
, Kudela
E
, Danko
J
.Current approaches in the clinical management of pregnancy-associated breast cancer-pros and cons.
EPMA J. 2018
Jun 24;9(3):257-270. eCollection 2018 Sep. DOI:.17.
RCOG Green-top guideline No. 12. Pregnancy and breast cancer. UK royal college of obstetricians and Gynaecologists;
2011
.18.
Moher
D
, Liberati
A
, Tetzlaff
J
, Altman
DG
; PRISMA Group
. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
. BMJ
. 2009
Jul
;339
jul21 1
:b2535
.
[PubMed]
0959-813819.
Chamness
GC
, Bannayan
GA
, Landry
LA
Jr, Sheridan
PJ
, McGuire
WL
. Abnormal reproductive development in rats after neonatally administered antiestrogen (tamoxifen)
. Biol Reprod
. 1979
Dec
;21
(5
):1087
–90
.
[PubMed]
0006-336320.
Iguchi
T
, Hirokawa
M
, Takasugi
N
. Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen
. Toxicology
. 1986
Dec
;42
(1
):1
–11
.
[PubMed]
0300-483X21.
Diwan
BA
, Anderson
LM
, Ward
JM
. Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen
. Carcinogenesis
. 1997
Oct
;18
(10
):2009
–14
.
[PubMed]
0143-333422.
Tucker
MJ
, Adam
HK
, Patterson
JS
. Tamoxifen. In: Laurence
DR
, McLean
AE
, Wetherall
M
, editors. Safety testing of new drugs: laboratory predictions and clinical performance
. London
: Academic Press
; 1984
. pp. 125
–61
. [chapter 6
].23.
Cunha
GR
, Taguchi
O
, Namikawa
R
, Nishizuka
Y
, Robboy
SJ
. Teratogenic effects of tamoxifen on the developing human female genital tract
. Hum Pathol
. 1987
;18
:1132
–43
.
[PubMed]
0046-817724.
Hines
M
, Alsum
P
, Roy
M
, Gorski
RA
, Goy
RW
. Estrogenic contributions to sexual differentiation in the female guinea pig: influences of diethylstilbestrol and tamoxifen on neural, behavioral, and ovarian development
. Horm Behav
. 1987
Sep
;21
(3
):402
–17
.
[PubMed]
0018-506X25.
Durrani
S
, Akbar
S
, Heena
H
. Breast Cancer During Pregnancy
. Cureus
. 2018
Jul
;10
(7
):e2941
.
[PubMed]
2168-818426.
Halakivi-Clarke
L
, Cho
E
, Onojafe
I
, Liao
DJ
, Clarke
R
. Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring
. Clin Cancer Res
. 2000
Jan
;6
(1
):305
–8
.
[PubMed]
1078-043227.
Yamasaki
K
, Noda
S
, Muroi
T
, Mitoma
H
, Takakura
S
, Sakamoto
S
. Effects of in utero and lactational exposure to tamoxifen in SD rats
. Toxicol Lett
. 2005
Apr
;156
(2
):289
–96
.
[PubMed]
0378-427428.
Nobakht
M
, Najafzadeh
N
, Kordestani Shargh
B
. Effects of tamoxifen on morphological and ultrastructural aspects of developing hippocampus of rat
. Iran Biomed J
. 2009
Oct
;13
(4
):237
–43
.
[PubMed]
1028-852X29.
Tewari
K
, Bonebrake
RG
, Asrat
T
, Shanberg
AM
. Ambiguous genitalia in infant exposed to tamoxifen in utero
. [letter]
. Lancet
. 1997
Jul
;350
(9072
):183
.
[PubMed]
0140-673630.
Cullins
SL
, Pridjian
G
, Sutherland
CM
. Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation
. JAMA
. 1994
Jun
;271
(24
):1905
–6
.
[PubMed]
0098-748431.
Berger
JC
, Clericuzio
CL
. Pierre Robin sequence associated with first trimester fetal tamoxifen exposure
. Am J Med Genet A
. 2008
Aug
;146A
(16
):2141
–4
.
[PubMed]
1552-482532.
Isaacs
RJ
, Hunter
W
, Clark
K
. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—case report and literature review
. Gynecol Oncol
. 2001
Mar
;80
(3
):405
–8
.
[PubMed]
0090-825833.
Li
RH
, Tam
WH
, Ng
PC
, Mok
TS
, Tam
B
, Lau
TK
. Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report
. J Reprod Med
. 2007
Jun
;52
(6
):575
–6
.
[PubMed]
0024-775834.
Koizumi
K
, Aono
T
. Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas
. Fertil Steril
. 1986
Aug
;46
(2
):312
–4
.
[PubMed]
0015-028235.
Oksüzoglu
B
, Güler
N
. An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy
. Eur J Obstet Gynecol Reprod Biol
. 2002
Aug
;104
(1
):79
.
[PubMed]
0301-211536.
Koca
T
, Akgun
Z
, Yucel
SB
, Dag
NZ
, Teomete
M
. Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature
. J Oncol Pharm Pract
. 2011
Dec
;17
(4
):440
–3
.
[PubMed]
1078-155237.
Koca
E
, Kuzan
TY
, Babacan
T
, Turkbeyler
IH
, Furkan
S
, Altundag
K
. Safety of tamoxifen during pregnancy: 3 case reports and review of the literature
. Breast Care (Basel)
. 2013
Dec
;8
(6
):453
–4
.
[PubMed]
1661-379138.
Ishizuka
S
, Satou
S
. A case of delivery of healthy infant in breast cancer patient incidentally treated with goserelin acetate and tamoxifen during pregnancy
. Breast Cancer
. 2016
Jan
;23
(1
):164
–6
.
[PubMed]
1340-686839.
Jyoti
B
, Bharat
C
, Ankita
N
, Munita
B
, Sudeep
G
. Pregnancy on tamoxifen: case-report and review of literature
. South Asian J Cancer
. 2016
Oct-Dec
;5
(4
):209
–10
.
[PubMed]
2278-330X40.
Mohamed
KEH
, Mirghani
S
. Breast Cancer Case using Tamoxifen during Pregnancy: A Case Report and Literature Review.
Sudan Journal of Medical Sciences Volume 12, Issue no. 2. DOI:.41.
Andreadis
C
, Charalampidou
M
, Diamantopoulos
N
, Chouchos
N
, Mouratidou
D
. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer
. Gynecol Oncol
. 2004
Oct
;95
(1
):252
–5
.
[PubMed]
0090-825842.
Beale
JM
, Tuohy
J
, McDowell
SJ
. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios
. Am J Obstet Gynecol
. 2009
Jul
;201
(1
):e13
–4
.
[PubMed]
0002-937843.
Warraich
Q
, Smith
N
. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios
. J Obstet Gynaecol
. 2009
Feb
;29
(2
):147
–8
.
[PubMed]
0144-361544.
Dipaola
RS
, Goodin
S
, Ratzell
M
, Florczyk
M
, Karp
G
, Ravikumar
TS
. Chemotherapy for metastatic melanoma during pregnancy
. Gynecol Oncol
. 1997
Sep
;66
(3
):526
–30
.
[PubMed]
0090-825845.
Grandvuillemin
A
, Rousseau
T
, Laurent
N
, Meyer
F
, Lebouvier
M
, Disson-Dautriche
A
. A case of sexual ambiguity under tamoxifen during pregnancy
. Fundam Clin Pharmacol
. 2009
;23
Suppl 1
:37
.0767-398146.
Phillips
DH
, Venitt
S
. Safety of prophylactic tamoxifen
. Lancet
. 1993
Jun
;341
(8858
):1485
–6
.
[PubMed]
0140-673647.
Schuurman
TN
, Witteveen
PO
, van der Wall
E
, Passier
JL
, Huitema
AD
, Amant
F
, et al. Tamoxifen and pregnancy: an absolute contraindication?
Breast Cancer Res Treat
. 2019
May
;175
(1
):17
–25
.
[PubMed]
0167-680648.
Lambertini
M
, Martel
S
, Campbell
C
, Guillame
S
, Hilbers
FS
, Schuenly
U
, et al. Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials
. Cancer
. 2018
Oct
;•••
:
[PubMed]
0008-543X49.
Peccatori
FA
, Azim
HA
Jr, Orecchia
R
, Hoekstra
HJ
, Pavlidis
N
, Kesic
V
, et al.; ESMO Guidelines Working Group
. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
. Ann Oncol
. 2013
Oct
;24
Suppl 6
:vi160
–70
.
[PubMed]
0923-753450.
Loibl
S
, Schmidt
A
, Gentilini
O
, Kaufman
B
, Kuhl
C
, Denkert
C
, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients
. JAMA Oncol
. 2015
Nov
;1
(8
):1145
–53
.
[PubMed]
2374-243751.
Lambertini
M
, Di Maio
M
, Pagani
O
, Curigliano
G
, Poggio
F
, Del Mastro
L
, et al. The BCY3/BCC 2017 survey on physicians’ knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients
. Breast
. 2018
Dec
;42
:41
–9
.
[PubMed]
0960-977652.
Correa
A
, Cragan
JD
, Kucik
JE
, Alverson
CJ
, Gilboa
SM
, Balakrishnan
R
, et al. Reporting birth defects surveillance data 1968-2003
. Birth Defects Res A Clin Mol Teratol
. 2007
Feb
;79
(2
):65
–186
.
[PubMed]
1542-075253.
National Toxicology Program
. NTP Monograph: Developmental Effects and Pregnancy Outcomes Associated With Cancer Chemotherapy Use During Pregnancy
. NTP Monogr
. 2013
May
;(2
):i-214
.
[PubMed]
2330-127954.
Gompel
A
, Ramirez
I
, Bitzer
J
; European Society of Contraception Expert Group on Hormonal Contraception
. Contraception in cancer survivors - an expert review Part I. Breast and gynaecological cancers
. Eur J Contracept Reprod Health Care
. 2019
Jun
;24
(3
):167
–74
.
[PubMed]
1362-518755.
Dominick
S
, Hickey
M
, Chin
J
, Su
HI
. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
. Cochrane Database Syst Rev
. 2015
Dec
;(12
):CD007245
.
[PubMed]
1469-493X56.
Medica
AC
, Stark
SS
, Hadnott
TN
, Dietz
AC
, Romero
SA
, Natarajan
L
, et al. Use of emergency contraception among female young adult cancer survivors
. Fertil Steril
. 2018
Jun
;109
(6
):1114
–1120.e1
.
[PubMed]
0015-0282© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
